In gastric GISTs, aberrant activation of KIT and PDGFRA promotes tumor growth and progression by stimulating cell cycle progression, enhancing angiogenesis, and facilitating evasion of immune surveillance mechanisms. This evidence concerns the gene KIT and neoplasm.